Investment Advisor Bets CMPX Stock: Big Stake Signals Conviction
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
Knowing when to save instead of invest is crucial for financial planning. Learn the key moments to prioritize saving for your needs.
24,071 articlesA prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
A small group of everyday investors rode space-data trends to multimillion-dollar gains years before a SpaceX IPO hea...
With burnout on the rise in early 2026, workers seek structured ways to reduce load without leaving their jobs. Inves...
When a top executive sells stock, it sparks questions about the company’s prospects. This guide breaks down insider m...
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
Two executive actions aim to accelerate quantum tech and prepare for encryption threats, sparking a rally in quantum-...
Kalshi launches its Brazil prediction market through XP International, reframing macro bets as regulated derivatives....
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
As 2026 unfolds, I’m leaning into one magnificent ETF that fits my high-conviction approach. Here’s why this fund sta...
A single number points toward Bitcoin’s potential upside over the long run. This guide breaks down how a real-world a...
As Palantir rolls out its Agentic AI Platform, analysts clash over value. This article breaks down the upside, the ri...
A Vanguard ETF focused on international stocks could unlock long-term gains as valuations normalize and growth divers...